Position in EXEL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,013,499
+$914,097 QoQ
Shares Held
73,764
+2.1% QoQ
Ownership
0.030%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
#191
of 751 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026OAK ASSOCIATES LTD /OH/ holds $19,769,546 across 6 Biotechnology names. EXEL ranks #3 (20.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
10,560 | $6,584,582 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
17,722 | $4,270,470 | |
| 3 | EXEL |
Exelixis, Inc.
This page
|
73,764 | $4,013,499 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
4,677 | $2,323,206 | |
| 5 | INCY |
Incyte Corp
|
18,643 | $2,113,370 | |
| 6 | INVA |
Innoviva, Inc.
|
20,450 | $464,419 |
All Filings in EXEL
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,013,499 | 73,764 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $3,099,402 | 72,264 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $3,448,938 | 78,689 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $3,574,267 | 86,544 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $3,814,859 | 86,544 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $3,195,204 | 86,544 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $2,881,915 | 86,544 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $2,504,616 | 96,517 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $2,730,486 | 121,517 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $2,883,598 | 121,517 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $2,915,192 | 121,517 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,707,127 | 123,896 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $2,367,652 | 123,896 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $2,404,821 | 123,896 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $1,397,356 | 87,117 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $1,557,698 | 99,343 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $2,068,321 | 99,343 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $2,252,105 | 99,343 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $1,815,990 | 99,343 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $2,100,111 | 99,343 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,810,029 | 99,343 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $2,171,237 | 96,115 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $1,928,526 | 96,090 | Shares | Sole | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||